Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02569060
Other study ID # A125548
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 2015
Est. completion date October 31, 2017

Study information

Verified date May 2020
Source University of California, San Francisco
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The Feeding America Intervention Trial for Health—Diabetes Mellitus (FAITH-DM) is a randomized, controlled study of the implementation of a diabetes intervention in food pantry settings.


Description:

For adults with diabetes mellitus, diabetes self-management education (DSME) is critical to achieving long-term control of blood sugar levels (glycemic control) and preventing diabetes-associated complications. This education is often difficult to access for highly vulnerable and marginalized adults in the United States. Furthermore, foods for a diabetic diet are often out of reach for food insecure households. The purpose of this study is to determine the extent to which food banks and food pantries can help reach this population with effective DSME, food, and access to primary health care. The investigators' primary outcome of interest is HbA1c improvement in the intervention group compared to a wait-listed control group of food pantry clients living with uncontrolled type 2 diabetes.


Recruitment information / eligibility

Status Completed
Enrollment 568
Est. completion date October 31, 2017
Est. primary completion date October 31, 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Food pantry client at one of three participating food banks: Alameda County Community Food Bank (Oakland, CA), Gleaners Community Food Bank of Southeastern Michigan (Detroit, MI), Houston Food Bank, (Houston, TX)

- Type II diabetes mellitus with HbA1c = 7.5% using food bank point-of-care testing

- Reliable mode of contact (either phone or address)

- English or Spanish verbal fluency

- 18 years of age or older

- Intent to remain in the study area for at least the next 12 months

- Willingness to participate in intervention

Exclusion Criteria:

- Type 1 diabetes

- Pregnant or less than 6 weeks post-partum

- Cognitively impaired: dementia, mental illness, or active substance abuse severe enough to interfere with administration of the survey or participation in the intervention

- Household member already enrolled in the study

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Testing and Monitoring of Blood Glucose Levels
Point-of-care testing of HbA1c levels at the food pantry at approximately 3 month intervals
Primary care coordination
Referral to a local primary care provider, if none currently exists. Coordination of care with primary care provider.
Diabetes-appropriate food packages
Food (perishable and non-perishable) appropriate for diabetes self-management available for pick-up at the food pantry twice monthly.
Behavioral:
Diabetes self-management education
Education materials drawn from evidence-based practice and adapted from existing diabetes education curricula to be flexible to individual, community, and site variations. The Immediate Intervention Arm receives more robust diabetes self-management education (with group education visits) than the Waitlist Control Arm.

Locations

Country Name City State
United States Gleaners Community Food Bank of Southeastern Michigan Detroit Michigan
United States Houston Food Bank Houston Texas
United States Alameda County Community Food Bank Oakland California
United States University of California San Francisco San Francisco California

Sponsors (4)

Lead Sponsor Collaborator
University of California, San Francisco Feeding America, Laura and John Arnold Foundation, Urban Institute

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Change from Baseline Diabetes Self-Efficacy 8-item scale of diabetes-specific self-efficacy 6 months and 12 months
Other Change from Baseline Diabetes Self-Care Self-reported assessment of 5 self-care behaviors: medications, exercise, diet, blood sugar monitoring, and foot care 6 months and 12 months
Primary Change from Baseline HbA1c at 6 Months Point-of-care HbA1c testing with the PTS Diagnostics A1CNow®+ System 6 months
Secondary Change from Baseline Dietary Intake Brief fruit & vegetable dietary screener 6 months and 12 months
Secondary Change from Baseline Health Care Utilization Communication with primary care provider requesting dates of service, service levels, and diagnosis codes 6 months and 12 months
Secondary Change from Baseline Diabetes Distress Self-reported distress as assessed by the 2-item emotional burden sub-score of the Diabetes Distress Scale 6 months and 12 months
Secondary Change from Baseline Hypoglycemic events Self-reported hypoglycemic events over the previous 4 weeks, both any events and number of events, and self-reported severe hypoglycemic episodes, both any events and number of events 6 months and 12 months
Secondary Change from Baseline Depressive symptoms PHQ-8 (a subset of PHQ-9 scores without assessment of suicidality) 6 months and 12 months
Secondary Change from Baseline Medication Adherence Morisky Medication Adherence Scale (4 items) 6 months and 12 months
Secondary Food vs medicine trade-offs Three self-reported questions 6 months and 12 months
Secondary Change from Baseline Food security status 6-item version of the USDA's Core Food Security Survey Module 6 months and 12 months
Secondary Change from Baseline Food stability Two items assessing adequacy of food resources to last the entire month 6 months and 12 months
See also
  Status Clinical Trial Phase
Completed NCT03743779 - Mastering Diabetes Pilot Study
Completed NCT03786978 - Pharmaceutical Care in the Reduction of Readmission Rates in Diabetes Melitus N/A
Completed NCT01804803 - DIgital Assisted MONitoring for DiabeteS - I N/A
Completed NCT05039970 - A Real-World Study of a Mobile Device-based Serious Health Game on Session Attendance in the National Diabetes Prevention Program N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Completed NCT04068272 - Safety of Bosentan in Type II Diabetic Patients Phase 1
Completed NCT03243383 - Readmission Prevention Pilot Trial in Diabetes Patients N/A
Completed NCT03730480 - User Performance of the CONTOUR NEXT and CONTOUR TV3 Blood Glucose Monitoring System (BGMS) N/A
Recruiting NCT02690467 - Efficacy, Safety and Acceptability of the New Pen Needle 34gx3,5mm. N/A
Completed NCT02229383 - Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus Phase 3
Completed NCT06181721 - Evaluating Glucose Control Using a Next Generation Automated Insulin Delivery Algorithm in Patients With Type 1 and Type 2 Diabetes N/A
Completed NCT05799976 - Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure N/A
Recruiting NCT04489043 - Exercise, Prediabetes and Diabetes After Renal Transplantation. N/A
Withdrawn NCT03319784 - Analysis for NSAID VS Corticosteroid Shoulder Injection in Diabetic Patients Phase 4
Completed NCT03542084 - Endocrinology Auto-Triggered e-Consults N/A
Completed NCT02229396 - Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo Phase 3
Recruiting NCT05544266 - Rare and Atypical Diabetes Network
Completed NCT01892319 - An International Non-interventional Cohort Study to Evaluate the Safety of Treatment With Insulin Detemir in Pregnant Women With Diabetes Mellitus. Diabetes Pregnancy Registry
Completed NCT05031000 - Blood Glucose Monitoring Systems: Discounter Versus Brand N/A
Recruiting NCT04039763 - RT-CGM in Young Adults at Risk of DKA N/A